151 related articles for article (PubMed ID: 35689792)
1. Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China.
Zhou Y; Qin Y; Lu Y; Yuan J; Nie J; Liu M; Tian Q; Lan K; Zhou G; Qin Y; He K; Yu J; Jiang Z; Liu J; Liu S; Harypursat V; Chen Y
Infect Dis Ther; 2022 Aug; 11(4):1575-1590. PubMed ID: 35689792
[TBL] [Abstract][Full Text] [Related]
2. Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study.
Zhou Y; Lu T; Li Y; Qin Y; Lu Y; Tian Q; Lan K; Zhou G; Qin Y; Harypursat V; Li S; Lin S; Chen Y
BMC Infect Dis; 2023 Oct; 23(1):707. PubMed ID: 37864131
[TBL] [Abstract][Full Text] [Related]
3. Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Zhao T; Xu X; Wu Y; Zhang W; Zeng Q; Lu Y; Yang T; Zhou G; Yu J; Lan K; Harypursat V; Chen Y
BMC Infect Dis; 2022 Aug; 22(1):677. PubMed ID: 35941618
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
Huang W; Li T; Zhou C; Wei F; Cao C; Jiang J
Mycopathologia; 2021 May; 186(2):269-276. PubMed ID: 33616828
[TBL] [Abstract][Full Text] [Related]
5. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.
Le T; Kinh NV; Cuc NTK; Tung NLN; Lam NT; Thuy PTT; Cuong DD; Phuc PTH; Vinh VH; Hanh DTH; Tam VV; Thanh NT; Thuy TP; Hang NT; Long HB; Nhan HT; Wertheim HFL; Merson L; Shikuma C; Day JN; Chau NVV; Farrar J; Thwaites G; Wolbers M;
N Engl J Med; 2017 Jun; 376(24):2329-2340. PubMed ID: 28614691
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
9. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
11. A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.
Flynn E; Marciniak A; Barbabietola G; Oppenheim BA; Roberts C; Barker K
J Clin Nurs; 2009 Apr; 18(8):1168-79. PubMed ID: 19017372
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus-Infected Adults in Vietnam.
Buchanan J; Altunkaya J; Van Kinh N; Van Vinh Chau N; Trieu Ly V; Thi Thanh Thuy P; Hai Vinh V; Thi Hong Hanh D; Thuy Hang N; Phuong Thuy T; van Doorn R; Thwaites G; Gray A; Le T
Open Forum Infect Dis; 2021 Jul; 8(7):ofab357. PubMed ID: 34337101
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B formulations: a comparative review of efficacy and toxicity.
Hamill RJ
Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
Oude Lashof AM; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Schlamm HT; Rex JH; Kullberg BJ
Antimicrob Agents Chemother; 2012 Jun; 56(6):3133-7. PubMed ID: 22450974
[TBL] [Abstract][Full Text] [Related]
15. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
[TBL] [Abstract][Full Text] [Related]
16. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study.
Batista MV; Ussetti MP; Jiang Y; Neofytos D; Cortez AC; Feriani D; Schmidt-Filho J; França-Silva ILA; Raad I; Hachem R
J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836281
[TBL] [Abstract][Full Text] [Related]
17. Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Min WS; Shin WS
Korean J Intern Med; 2006 Sep; 21(3):165-72. PubMed ID: 17017665
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.
González GM; González G; Najvar LK; Graybill JR
J Antimicrob Chemother; 2007 Dec; 60(6):1341-6. PubMed ID: 17934204
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate---fat emulsion in HIV-infected patients with oral candidosis.
Chavanet P; Clement C; Duong M; Buisson M; D'Athis P; Dumas M; Bonnin A; Portier H
Clin Microbiol Infect; 1997 Aug; 3(4):455-461. PubMed ID: 11864156
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort.
Klus J; Ly VT; Chan C; Le T
Med Mycol; 2021 Apr; 59(4):392-399. PubMed ID: 33644813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
